Guillermo J Pons-Estel Selected Research

Thrombocytopenia (Thrombopenia)

1/2019	The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
1/2016	Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guillermo J Pons-Estel Research Topics

Disease

7	COVID-19 08/2023 - 01/2021
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 06/2009
4	Autoimmune Diseases (Autoimmune Disease) 09/2023 - 09/2011
4	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2023 - 11/2013
4	Lupus Nephritis 01/2022 - 06/2009
3	Rheumatoid Arthritis 08/2023 - 01/2021
3	Thrombosis (Thrombus) 08/2023 - 01/2017
3	Hypertension (High Blood Pressure) 01/2022 - 07/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 06/2022 - 06/2009
2	Proteinuria 12/2020 - 06/2009
2	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2016
1	Infections 03/2023
1	Rheumatic Diseases (Rheumatism) 02/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Leukopenia 10/2021
1	Serositis 10/2021
1	Necrosis 01/2021
1	Renal Hypertension 12/2020
1	Cognitive Dysfunction 01/2019
1	Hemolytic Anemia 01/2019
1	Lymphopenia (Lymphocytopenia) 01/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2013
1	Myocardial Infarction 11/2013
1	Stroke (Strokes) 11/2013
1	Infarction (Infarctions) 03/2010
1	Exanthema (Rash) 03/2010
1	Glomerulonephritis 06/2009

Drug/Important Bio-Agent (IBA)

5	Antiphospholipid AntibodiesIBA 08/2023 - 11/2013
4	AntibodiesIBA 12/2020 - 09/2011
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 09/2023 - 06/2009
3	GlucocorticoidsIBA 03/2023 - 06/2009
3	Rituximab (Mabthera)FDA Link 02/2023 - 01/2021
3	Antimalarials (Antimalarial Agents)IBA 12/2020 - 07/2012
2	Immunoglobulin G (IgG)IBA 08/2023 - 01/2019
2	COVID-19 VaccinesIBA 08/2023 - 12/2022
2	Immunomodulating AgentsIBA 03/2023 - 10/2022
2	Oxygen (Dioxygen)IBA 02/2023 - 01/2021
2	VaccinesIBA 12/2022 - 10/2022
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2021
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 12/2020
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 12/2020
2	Complement System Proteins (Complement)IBA 12/2020 - 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2023
1	Vitamin K FDA Link 08/2023
1	AnticoagulantsIBA 08/2023
1	Calcineurin InhibitorsIBA 01/2022
1	voclosporinIBA 01/2022
1	anifrolumabIBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Abatacept (Orencia)FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	CreatinineIBA 12/2020
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	amsonic acid (DAS)IBA 12/2017
1	AutoantibodiesIBA 01/2017
1	Azathioprine (Imuran)FDA LinkGeneric 01/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 09/2011

Therapy/Procedure

2	Therapeutics 06/2022 - 01/2022
1	Plasma Exchange 09/2011
1	Kidney Transplantation 09/2009
1	Transplantation 06/2009